Sales and Marketing

Showing 15 posts of 11527 posts found.

Charities invest £4.2m for London biosciences hub

June 11, 2013 Research and Development, Sales and Marketing Biochemical Society, London hub, Society for General Microbiology, Society of Biology

A collective of five charitable societies have come together to create a new bioscience hub in central London. The offices …

Questcor hires Shire’s chief executive

June 11, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Questcor, Shire

Biopharma firm Questcor Pharmaceuticals has appointed the recently-retired chief executive of Shire to its Board of directors.   Angus Russell …

Novartis works in MS switch

June 11, 2013 Research and Development, Sales and Marketing MS, Novartis, gilenya

Novartis’ oral MS drug Gilenya has been found to help multiple sclerosis (MS) patients who switch to it after taking …

High cure rate for Boehringer HCV drug

June 11, 2013 Research and Development, Sales and Marketing Boehringer Ingelheim, HCV

One of Boehringer Ingelheim’s pipeline drugs has achieved high response rates in patients with chronic genotype-1 hepatitis C virus (HCV) in …

AstraZeneca to pay up to $1.2 billion for Pearl

June 10, 2013 Research and Development, Sales and Marketing AstraZeneca, COPD, pearl therapeutics

AstraZeneca is betting big on lung disease specialist Pearl Therapeutics as it looks to spend $1.2 billion to acquire the …

Department of Health prioritises Francis response

June 7, 2013 Sales and Marketing DH, Francis, Mid Staffs, NHS

The Department of Health has set out its priorities for the next year, explaining how it will enhance public health …

Working Life, Vifor Pharma, Derek Williams

June 7, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vifor pharma, Working Life, williams

How did you find your way into your current role? I began my career in the UK as a sales …

NICE thumbs-up for Abilify

June 7, 2013 Sales and Marketing Abilify, BMS, NICE, Otsuka

Adolescents who suffer from bipolar disorder should be treated on the NHS with Otsuka Pharmaceuticals’ Abilify, according to draft guidance …

Novartis receives FDA warning

June 6, 2013 Manufacturing and Production, Sales and Marketing CGMP, FDA, GMP, Novartis

The FDA has castigated Novartis for what it calls ‘significant violations’ of current good manufacturing practice (CGMP) regulations for finished …

Mirna appoints ex-Pfizer senior director

June 6, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, miRNA

Biotech firm Mirna Therapeutics has appointed Dr Sinil Kim as vice president of Oncology and chief medical officer. Kim will …

Bayer takes over Conceptus

June 6, 2013 Sales and Marketing Bayer, Conceptus

The Bayer Group, which contains Bayer HealthCare, has taken over US contraception specialist Conceptus in a $1.1 billion deal. The …

Aveo to cut workforce after FDA knock-back

June 6, 2013 Research and Development, Sales and Marketing Aveo, FDA, cuts, tivozanib

Aveo will make major jobs cuts this year after news that a kidney cancer licence for its oncology drug tivozanib …

Novartis drug shows cancer promise

June 5, 2013 Research and Development, Sales and Marketing ASCO, Cancer, Novartis

A Novartis drug which has been given breakthrough therapy designation by the FDA has demonstrated early promise in patients with …

Celgene predicts trio of blockbusters

June 5, 2013 Sales and Marketing Celgene, Pomalidomide, Revlamid, Velcade

Europe’s medicines committee the CHMP has just adopted a positive opinion for Celgene’s new multiple myeloma treatment Pomalidomide Celgene (pomalidomide). …

HAVAS LYNX makes several leadership changes

June 5, 2013 Medical Communications, Sales and Marketing Creative Lynx, HAVAS LYNX, PM Society Digital Awards

Comms agency HAVAS LYNX has realigned its senior team making a number of changes for the global firm as it …
The Gateway to Local Adoption Series

Latest content